By Benjamin Chiou
Date: Friday 19 Dec 2025
(Sharecast News) - Shares in BioMarin surged on Wall Street on Friday after the pharma group agreed to buy smaller peer Amicus Therapeutics for $4.8bn, expanding its position in the rare diseases market.
| Republicans toast healthcare victory as Trump sa... | 05-May-2017 | ShareCast |
| Abbott in $6.6 Billion Deal for Drug Unit | 29-Sep-2009 | New York Times |
| Market movers | 21-Feb-2007 | Chicago Tribune |
| Stock Futures Slip; Tech Shares in Focus | 19-Dec-2006 | Chicago Tribune |
| FrankfurtStocks.com Highlights HS3 Technologies,... | 16-Mar-2006 | Marketwired |
| Currency | US Dollars |
| Share Price | $ 60.16 |
| Change Today | $ -0.98 |
| % Change | -1.60 % |
| 52 Week High | $72.83 |
| 52 Week Low | $51.46 |
| Volume | 1,209,245 |
| Shares Issued | 179.84m |
| Market Cap | $10,819m |
| RiskGrade | 181 |
| Strong Buy | 10 |
| Buy | 8 |
| Neutral | 5 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 24 |

You are here: research